
“The Tribute Plan is a powerful reflection of our mission to advance, protect, and reward the practice of good medicine,” said Richard E. Anderson, MD, FACP, chairman and CEO of The Doctors Company and TDC Group. “It represents our long-term commitment to our members—and to the practice of medicine itself.”
Backed by the company’s financial strength of $7.8 billion in assets and $3.1 billion in member surplus, the Tribute Plan has received continuous annual funding since its launch. The Doctors Company funds Tribute from its own capital — not premiums — and Tribute payments are in addition to the company’s ongoing dividend program.
Leave a Reply